Literature DB >> 20455724

Cardiovascular risk factors in polycystic ovary syndrome.

A Karaer1, S Cavkaytar, I Mert, U Buyukkagnici, S Batioglu.   

Abstract

A total of 31 women with polycystic ovary syndrome (PCOS) and 31 healthy age/body mass index matched controls were compared for serum hormones, basal and oral-glucose stimulated glucose, insulin, homocysteine, high sensitive C-reactive protein (hsCRP) and lipid levels. The women with PCOS had significantly higher serum fasting insulin, homocysteine, total cholesterol and LDL cholesterol level than controls, whereas no differences were detected in serum fasting or OGTT 60th- and 120th-minute glucose concentrations, hsCRP, HDL cholesterol, VLDL cholesterol and triglyceride levels between PCOS and control women. Insulin resistance was found in 54.8% (17/31) of PCOS patients by glucose: insulin (G/I) ratio, whereas only 29.0% (9/31) of control women (p = 0.04). Multivariate linear regression analysis revealed that only waist/hip ratio was independent determinants of G/I ratio. PCOS is associated with some biochemical and clinical risk factors for cardiovascular disease. Therefore, patients with PCOS should undergo comprehensive evaluation for recognised cardiovascular risk factors.

Entities:  

Mesh:

Year:  2010        PMID: 20455724     DOI: 10.3109/01443611003763408

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  6 in total

1.  Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.

Authors:  U Durmus; C Duran; S Ecirli
Journal:  J Endocrinol Invest       Date:  2016-11-12       Impact factor: 4.256

2.  Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome.

Authors:  Ebru Çelik; Ilgın Türkçüoğlu; Barış Ata; Abdullah Karaer; Pınar Kırıcı; Sevil Eraslan; Çağatay Taşkapan; Bülent Berker
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01

3.  Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes.

Authors:  Berna Dilbaz; Enis Ozkaya; Mehmet Cinar; Evrim Cakir; Serdar Dilbaz
Journal:  Endocrine       Date:  2011-03-10       Impact factor: 3.633

4.  High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome.

Authors:  Tayebe Hemati; Nasrin Moghadami-Tabrizi; Fateme Davari-Tanha; Bahram Salmanian; Pouya Javadian
Journal:  Iran J Reprod Med       Date:  2011

5.  Role of Single Nucleotide Variants in the YAP1 Gene in Adolescents with Polycystic Ovary Syndrome.

Authors:  Lasma Lidaka; Laine Bekere; Gunta Lazdane; Marija Lazovska; Iveta Dzivite-Krisane; Linda Gailite
Journal:  Biomedicines       Date:  2022-07-13

Review 6.  Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Yuming Meng; Xiang Chen; Zheng Peng; Xuexiang Liu; Yifan Sun; Shengming Dai
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.